Henry Schein Inc. ranked 303 on the 2012 FORTUNE 500 list of largest U.S. public companies, which is based on 2011 revenue. The dental products distributor moved up 14 spots with revenue of $8.5 billion, a gain of 13.3% from 2010. According to Henry Schien CEO Stanley Bergman, 54% of Schein's business is in the dental space. Technology is responsible for 13% of the company's profits.
Henry Schein Inc. ranked 303 on the 2012 FORTUNE 500 list of largest U.S. public companies, which is based on 2011 revenue. The dental products distributor moved up 14 spots with revenue of $8.5 billion, a gain of 13.3% from 2010.
According to Henry Schien CEO Stanley Bergman, 54% of Schein's business is in the dental space. Technology is responsible for 13% of the company's profits.
"Technology provides value added services to the practitioners and clinicians to help them run a better business so they can provide better clinical care," said Bergman in a video interview with Pimm Fox on Bloomberg TV. "The exciting part is the practice management software, the software that deals with electronic charting and integrating digital x-ray into the practice management software."
"We are very pleased by this recognition of our ability to record steady growth even during challenging economic times," said Bergman "Our success has been the result of our nearly 15,000 Team Schein Members worldwide executing a clear strategic plan, and providing our dental, medical and animal health customers with the products and services needed to operate efficient practices and deliver quality care to patients."
In addition to the Company's 2012 FORTUNE ranking, Henry Schein also ranked number one overall in the "Wholesalers: Health Care" industry in FORTUNE's 2012 list of the "World's Most Admired Companies." Henry Schein earned the highest overall ranking in its industry, "Wholesalers: Health Care."
The Company repeated its first-place ranking from 2011 in the categories of Social Responsibility and Global Competitiveness, and ranked first in the categories of Quality of Management, Quality of Products/Services and Long-Term Investment.
Henry Schein ranked second among other industry companies in the four remaining categories (Innovation, People Management, Use of Corporate Assets and Financial Soundness).
ACTIVA BioACTIVE Bulk Flow Marks Pulpdent’s First Major Product Release in 4 Years
December 12th 2024Next-generation bulk-fill dental restorative raises the standard of care for bulk-fill procedures by providing natural remineralization support, while also overcoming current bulk-fill limitations.